BioXcel Therapeutics (BTAI) Income Statement (2017 - 2026)
Income Statement report data from Mar 31, 2017 to Mar 31, 2026 for BioXcel Therapeutics (BTAI).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||||||||||
Total Revenue | 210K (-19.23%) | 260K (+160.00%) | 100K (-16.67%) | 120K (-29.41%) | 170K (-54.05%) | 370K (+76.19%) | 210K (-80.91%) | 1.10M (+89.66%) | 580K (+52.63%) | 380K (+11.76%) | 340K (-26.09%) | 460K (+119.05%) | 210K (-12.50%) | 240K (+71.43%) | 140K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||||||||||
Research And Development | 2.96M (-55.82%) | 6.70M (-23.34%) | 8.74M (-14.81%) | 10M (+125.49%) | 4.55M (-22.88%) | 5.90M (+15.69%) | 5.10M (-36.49%) | 8.03M (-29.56%) | 11M (+14.80%) | 9.93M (-49.39%) | 20M (-27.25%) | 27M (-2.99%) | 28M (-15.01%) | 33M (+48.28%) | 22M (+23.17%) | 18M (-3.50%) | 19M (+48.12%) | 13M (+5.03%) | 12M (-11.70%) | 14M (-8.34%) | 15M (+29.30%) | 11M (-30.15%) | 16M (-8.88%) | 18M (+44.79%) | 12M (+90.31%) | 6.50M (-8.71%) | 7.12M (+9.37%) | 6.51M (+14.81%) | 5.67M (-5.81%) | 6.02M (+57.59%) | 3.82M (+114.61%) | 1.78M (-39.46%) | 2.94M (+105.59%) | 1.43M (+130.65%) | 620K (+93.75%) | 320K (0.00%) | 320K |
Selling General And Administrative | 7.19M (+88.71%) | 3.81M (-29.18%) | 5.38M (-4.10%) | 5.61M (-1.58%) | 5.70M (+39.02%) | 4.10M (-46.61%) | 7.68M (-18.73%) | 9.45M (-28.73%) | 13M (+38.13%) | 9.60M (-60.56%) | 24M (-5.91%) | 26M (+9.62%) | 24M (+15.69%) | 20M (+19.65%) | 17M (-7.24%) | 18M (+42.26%) | 13M (-5.07%) | 14M (-8.53%) | 15M (+5.53%) | 14M (+21.13%) | 12M (+20.00%) | 9.70M (+14.79%) | 8.45M (+139.38%) | 3.53M (+34.22%) | 2.63M (+36.98%) | 1.92M (-4.48%) | 2.01M (-5.63%) | 2.13M (+21.71%) | 1.75M (+34.62%) | 1.30M (0.00%) | 1.30M (-10.96%) | 1.46M (+8.15%) | 1.35M (+22.73%) | 1.10M (+266.67%) | 300K (+25.00%) | 240K (+14.29%) | 210K |
Operating Expenses | 10M (-1.04%) | 11M (-26.45%) | 14M (-10.27%) | 16M (+55.50%) | 10M (-5.43%) | 11M (-29.98%) | 16M (-15.71%) | 18M (-25.66%) | 25M (+22.22%) | 20M (-58.37%) | 49M (-8.00%) | 53M (+2.86%) | 51M (-3.26%) | 53M (+35.78%) | 39M (+7.83%) | 36M (+15.28%) | 31M (+20.47%) | 26M (-2.54%) | 27M (-2.90%) | 28M (+4.66%) | 26M (+25.02%) | 21M (-14.82%) | 25M (+15.53%) | 21M (+42.93%) | 15M (+78.36%) | 8.41M (-7.89%) | 9.13M (+5.67%) | 8.64M (+16.44%) | 7.42M (+1.50%) | 7.31M (+42.77%) | 5.12M (+58.02%) | 3.24M (-24.48%) | 4.29M (+69.57%) | 2.53M (+175.00%) | 920K (+64.29%) | 560K (+5.66%) | 530K |
Depreciation And Amortization | 60K (-14.29%) | 70K (-12.50%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (-11.11%) | 90K (+12.50%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (0.00%) | 80K (+14.29%) | 70K (+40.00%) | 50K (0.00%) | 50K (0.00%) | 50K (0.00%) | 50K (-58.33%) | 120K | - | - | 40K (+100.00%) | 20K | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Income | -10.22M (-0.58%) | -10.28M (-27.76%) | -14.23M (-10.22%) | -15.85M (+56.93%) | -10.10M (-3.72%) | -10.49M (-31.39%) | -15.29M (-11.62%) | -17.30M (-28.39%) | -24.16M (+21.59%) | -19.87M (-58.86%) | -48.30M (-7.84%) | -52.41M (+2.36%) | -51.20M (-3.20%) | -52.89M (+35.65%) | -38.99M (+7.44%) | -36.29M (+15.28%) | -31.48M (+20.47%) | -26.13M (-2.54%) | -26.81M (-2.90%) | -27.61M (+4.66%) | -26.38M (+25.02%) | -21.10M (-14.82%) | -24.77M (+15.59%) | -21.43M (+42.87%) | -15.00M (+78.36%) | -8.41M (-7.89%) | -9.13M (+5.79%) | -8.63M (+16.31%) | -7.42M (+1.50%) | -7.31M (+42.77%) | -5.12M (+58.02%) | -3.24M (-24.48%) | -4.29M (+69.57%) | -2.53M (+175.00%) | -920.00K (+64.29%) | -560.00K (+5.66%) | -530.00K |
Ebit | -10.22M (-0.58%) | -10.28M (-27.76%) | -14.23M (-10.22%) | -15.85M (+56.93%) | -10.10M (-3.72%) | -10.49M (-31.39%) | -15.29M (-11.62%) | -17.30M (-28.39%) | -24.16M (+21.59%) | -19.87M (-58.86%) | -48.30M (-7.84%) | -52.41M (+2.36%) | -51.20M (-3.20%) | -52.89M (+35.65%) | -38.99M (+7.44%) | -36.29M (+15.28%) | -31.48M (+20.47%) | -26.13M (-2.54%) | -26.81M (-2.90%) | -27.61M (+4.66%) | -26.38M (+25.02%) | -21.10M (-14.82%) | -24.77M (+15.59%) | -21.43M (+42.87%) | -15.00M (+78.36%) | -8.41M (-7.89%) | -9.13M (+5.79%) | -8.63M (+16.31%) | -7.42M (+1.50%) | -7.31M (+42.77%) | -5.12M (+58.02%) | -3.24M (-24.48%) | -4.29M (+69.57%) | -2.53M (+175.00%) | -920.00K (+64.29%) | -560.00K (+5.66%) | -530.00K |
EBITDA | -10.16M (-0.49%) | -10.21M (-27.84%) | -14.15M (-10.33%) | -15.78M (+57.49%) | -10.02M (-3.84%) | -10.42M (-31.54%) | -15.22M (-11.61%) | -17.22M (-28.49%) | -24.08M (+21.62%) | -19.80M (-58.94%) | -48.22M (-7.85%) | -52.33M (+2.37%) | -51.12M (-3.20%) | -52.81M (+35.76%) | -38.90M (+7.46%) | -36.20M (+15.29%) | -31.40M (+20.54%) | -26.05M (-2.58%) | -26.74M (-2.87%) | -27.53M (+4.64%) | -26.31M (+24.99%) | -21.05M (-14.85%) | -24.72M (+15.57%) | -21.39M (+43.08%) | -14.95M (+74.04%) | -8.59M (-4.56%) | -9.00M (+6.26%) | -8.47M (+14.77%) | -7.38M (-4.77%) | -7.75M (+58.49%) | -4.89M (+61.39%) | -3.03M (-29.21%) | -4.28M (+69.17%) | -2.53M (+175.00%) | -920.00K (+64.29%) | -560.00K (+5.66%) | -530.00K |
Other Income / Expenses | |||||||||||||||||||||||||||||||||||||
Interest Income | 210K (-34.38%) | 320K (+33.33%) | 240K (+4.35%) | 230K (-17.86%) | 280K (-24.32%) | 370K (-40.32%) | 620K (-7.46%) | 670K (-29.47%) | 950K (0.00%) | 950K (-11.21%) | 1.07M (-33.95%) | 1.62M (-19.80%) | 2.02M (+35.57%) | 1.49M (+81.71%) | 820K (+310.00%) | 200K (+900.00%) | 20K (+100.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (0.00%) | 20K (-33.33%) | 30K (-66.67%) | 90K | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 3.70M (-5.85%) | 3.93M (0.00%) | 3.93M (+2.61%) | 3.83M (+5.22%) | 3.64M (-3.45%) | 3.77M (+2.45%) | 3.68M (+2.22%) | 3.60M (-0.28%) | 3.61M (+4.94%) | 3.44M (+5.85%) | 3.25M (-0.31%) | 3.26M (-3.26%) | 3.37M (+15.41%) | 2.92M (-21.08%) | 3.70M (+132.70%) | 1.59M (+15800.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (+100.00%) | 10K | - | 10K (0.00%) | 10K (0.00%) | 10K | - | 20K | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 210K (-34.38%) | 320K (+33.33%) | 240K (+4.35%) | 230K (-17.86%) | 280K (-92.96%) | 3.98M (+541.94%) | 620K (-7.46%) | 670K | -2.66M (+6.83%) | -2.49M (+14.22%) | -2.18M (+32.93%) | -1.64M (+21.48%) | -1.35M (-5.59%) | -1.43M (-50.35%) | -2.88M (+108.70%) | -1.38M | 10K (0.00%) | 10K | - | -10.00K | - | 10K (-50.00%) | 20K (0.00%) | 20K (-77.78%) | 90K | - | -20.00K | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 1.52M | -3.52M (-71.95%) | -12.55M | 660K (-89.94%) | 6.56M (-67.48%) | 20M (+318.46%) | 4.82M (-59.93%) | 12M (+40000.00%) | 30K (-92.31%) | 390K | - | 540K | -250.00K (-41.86%) | -430.00K | 60K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||||||||||||||
Net Income From Continuing Operations | -12.69M (+1.20%) | -12.54M (-59.43%) | -30.91M (+61.07%) | -19.19M (+164.69%) | -7.25M (-33.24%) | -10.86M (-20.44%) | -13.65M (+64.46%) | -8.30M (-69.02%) | -26.79M (+20.35%) | -22.26M (-55.91%) | -50.49M (-5.64%) | -53.51M (+1.34%) | -52.80M (-3.67%) | -54.81M (+31.12%) | -41.80M (+10.96%) | -37.67M (+19.70%) | -31.47M (+20.48%) | -26.12M (-2.57%) | -26.81M (-2.93%) | -27.62M (+4.70%) | -26.38M (+25.08%) | -21.09M (-14.79%) | -24.75M (+15.55%) | -21.42M (+43.66%) | -14.91M (+80.29%) | -8.27M (-8.31%) | -9.02M (+6.49%) | -8.47M (+17.64%) | -7.20M (+1.84%) | -7.07M (+44.58%) | -4.89M (+61.39%) | -3.03M (-29.21%) | -4.28M (+69.17%) | -2.53M (+175.00%) | -920.00K (+64.29%) | -560.00K (+5.66%) | -530.00K |
Net Income | -12.69M (+1.20%) | -12.54M (-59.43%) | -30.91M (+61.07%) | -19.19M (+164.69%) | -7.25M (-33.24%) | -10.86M (-20.44%) | -13.65M (+64.46%) | -8.30M (-69.02%) | -26.79M (+20.35%) | -22.26M (-55.91%) | -50.49M (-5.64%) | -53.51M (+1.34%) | -52.80M (-3.67%) | -54.81M (+31.12%) | -41.80M (+10.96%) | -37.67M (+19.70%) | -31.47M (+20.48%) | -26.12M (-2.57%) | -26.81M (-2.93%) | -27.62M (+4.70%) | -26.38M (+25.08%) | -21.09M (-14.79%) | -24.75M (+15.55%) | -21.42M (+43.66%) | -14.91M (+80.29%) | -8.27M (-8.31%) | -9.02M (+6.49%) | -8.47M (+17.64%) | -7.20M (+1.84%) | -7.07M (+44.58%) | -4.89M (+61.39%) | -3.03M (-29.21%) | -4.28M (+69.17%) | -2.53M (+175.00%) | -920.00K (+64.29%) | -560.00K (+5.66%) | -530.00K |